SlideShare une entreprise Scribd logo
1  sur  14
Télécharger pour lire hors ligne
HPV infection and anal dysplasia in Vancouver:   Preliminary findings from the ManCount Survey Dr. Mark Gilbert BC Centre for Disease Control Gay Men’s Health Summit, Nov 10 ‘09
Acknowledgements ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
ManCount Survey ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Self-collection of rectal swabs ,[object Object],[object Object],[object Object],[object Object],Lampinen et al.  STD 2006; 33(6):386-388.
Objective (Sub-study) ,[object Object],[object Object]
Methods ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Results - Participation In total, 252 specimens collected 239 (94.8%) specimens of sufficient quality for testing
Results – Anal Cytology ,[object Object],[object Object],[object Object],[object Object],[object Object],Lampinen et al.  STD 2006; 33(6):386-388. Specimen adequacy Number Percent Satisfactory for analysis 149 / 239 62% [56-69%] Unsatisfactory for analysis 90 / 239 38% [32-44%] Unsatisfactory for analysis  (Vanguard study, same protocol) 17% [12-22%]
Results – Anal cytology *satisfactory specimens only Prevalence estimates from other studies in pink font (setting, populations may vary). Category Total  (n=149) HIV+  (n=42) HIV- (n=107) Normal cytology 58%  [50-66%] 36%  [21-50%] 29-76% 66%  [57-75%] 68-100% High grade squamous intra-epithelial lesion (HSIL) 11%  [6-17%] 31% [17-45%] 5-22% 4% [0-7%] 3-5% Low grade squamous intra-epithelial lesion (LSIL) 19%  [13%-25%] 26% [13-40%] 19-49% 16% [9-23%] 7-5% Atypical results (ASCUS, ASC-H) 12% [7-17%] 7% [0-15%] 7-26% 14% [7-21%] 5%
Results – HPV infection Betaglobin (marker of adequacy) Number Percent Betaglobin positive  159 / 239 67% [62-72%] Betaglobin negative 80 / 239 33% [28-38%]
Results – HPV infection *Betaglobin positive specimens only ,[object Object],[object Object],Prevalence estimates from other studies in pink font (setting, populations, HPV classification  may vary).  Munoz, NEJM 2003; 348:518-527. Category Total (n=159) HIV+ (n=42) HIV- (n=116) HPV Negative 38% [30-45%] 17-35% 21% [9-33%] 6-65% 43% [34-52%] 8-60% Low Risk HPV type 37% [30-44%] 36-59% 62% [47-77%] 7-52% 28% [20-37%] 8-67% High Risk HPV type 47% [39-55%] 29-41% 71% [57-85%] 25-84% 39% [30-48%] 22-33%
Conclusions ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Next steps ,[object Object],[object Object]
[object Object],[object Object],[object Object]

Contenu connexe

Tendances

Report from the 21st International AIDS Conference – 2016 Durban, RSA
Report from the 21st International AIDS Conference – 2016 Durban, RSAReport from the 21st International AIDS Conference – 2016 Durban, RSA
Report from the 21st International AIDS Conference – 2016 Durban, RSAUC San Diego AntiViral Research Center
 
Attitudes, knowledge, and practices in relation to cervical
Attitudes, knowledge, and practices in relation to cervicalAttitudes, knowledge, and practices in relation to cervical
Attitudes, knowledge, and practices in relation to cervicalTariq Mohammed
 
Clinical Impact of New Data From IAS 2019
Clinical Impact of New Data From IAS 2019Clinical Impact of New Data From IAS 2019
Clinical Impact of New Data From IAS 2019hivlifeinfo
 
Prevalence of Hepatitis B Surface Antigen among Undergraduate Students of Gom...
Prevalence of Hepatitis B Surface Antigen among Undergraduate Students of Gom...Prevalence of Hepatitis B Surface Antigen among Undergraduate Students of Gom...
Prevalence of Hepatitis B Surface Antigen among Undergraduate Students of Gom...IOSR Journals
 
Современное лечение ВИЧ.Объединенные данные с конференции IAS 2019 / Contemp...
Современное лечение ВИЧ.Объединенные данные с конференции  IAS 2019 / Contemp...Современное лечение ВИЧ.Объединенные данные с конференции  IAS 2019 / Contemp...
Современное лечение ВИЧ.Объединенные данные с конференции IAS 2019 / Contemp...hivlifeinfo
 
Why, when, and how to use pre exposure prophylaxis for hiv acquisition. 2014
Why, when, and how to use pre exposure prophylaxis for hiv acquisition. 2014Why, when, and how to use pre exposure prophylaxis for hiv acquisition. 2014
Why, when, and how to use pre exposure prophylaxis for hiv acquisition. 2014Hivlife Info
 
Key Slides on ART for HIV : Evolving Concepts and Innovative Strategies.2020
Key Slides on ART for HIV : Evolving Concepts and Innovative Strategies.2020Key Slides on ART for HIV : Evolving Concepts and Innovative Strategies.2020
Key Slides on ART for HIV : Evolving Concepts and Innovative Strategies.2020hivlifeinfo
 
HPG PrEP Presentation by Dr. Kathleen Brady (AACO)
HPG PrEP Presentation by Dr. Kathleen Brady (AACO)HPG PrEP Presentation by Dr. Kathleen Brady (AACO)
HPG PrEP Presentation by Dr. Kathleen Brady (AACO)Office of HIV Planning
 
04.03.20 | COVID-19 and HIV: What We Know and Efforts to Answer What We Don’t...
04.03.20 | COVID-19 and HIV: What We Know and Efforts to Answer What We Don’t...04.03.20 | COVID-19 and HIV: What We Know and Efforts to Answer What We Don’t...
04.03.20 | COVID-19 and HIV: What We Know and Efforts to Answer What We Don’t...UC San Diego AntiViral Research Center
 
Bcn checkpoint - Michael Meulbroek
Bcn checkpoint - Michael MeulbroekBcn checkpoint - Michael Meulbroek
Bcn checkpoint - Michael MeulbroekReShape
 
Using Urine Point-of-Care Tenofovir Testing to Deliver Targeted PrEP Adherenc...
Using Urine Point-of-Care Tenofovir Testing to Deliver Targeted PrEP Adherenc...Using Urine Point-of-Care Tenofovir Testing to Deliver Targeted PrEP Adherenc...
Using Urine Point-of-Care Tenofovir Testing to Deliver Targeted PrEP Adherenc...HopkinsCFAR
 
Review from the 24th Conference on Retroviruses and Opportunistic Infections ...
Review from the 24th Conference on Retroviruses and Opportunistic Infections ...Review from the 24th Conference on Retroviruses and Opportunistic Infections ...
Review from the 24th Conference on Retroviruses and Opportunistic Infections ...UC San Diego AntiViral Research Center
 
Launch of Policy Cures: Improving Access to Diagnostics in the Developing Wor...
Launch of Policy Cures: Improving Access to Diagnostics in the Developing Wor...Launch of Policy Cures: Improving Access to Diagnostics in the Developing Wor...
Launch of Policy Cures: Improving Access to Diagnostics in the Developing Wor...LIDC
 

Tendances (19)

CROI 2015 FINAL
CROI 2015 FINALCROI 2015 FINAL
CROI 2015 FINAL
 
Report from the 21st International AIDS Conference – 2016 Durban, RSA
Report from the 21st International AIDS Conference – 2016 Durban, RSAReport from the 21st International AIDS Conference – 2016 Durban, RSA
Report from the 21st International AIDS Conference – 2016 Durban, RSA
 
04.10.20 | Updates in HIV Prevention from CROI 2020
04.10.20 | Updates in HIV Prevention from CROI 202004.10.20 | Updates in HIV Prevention from CROI 2020
04.10.20 | Updates in HIV Prevention from CROI 2020
 
Attitudes, knowledge, and practices in relation to cervical
Attitudes, knowledge, and practices in relation to cervicalAttitudes, knowledge, and practices in relation to cervical
Attitudes, knowledge, and practices in relation to cervical
 
Clinical Impact of New Data From IAS 2019
Clinical Impact of New Data From IAS 2019Clinical Impact of New Data From IAS 2019
Clinical Impact of New Data From IAS 2019
 
Prevalence of Hepatitis B Surface Antigen among Undergraduate Students of Gom...
Prevalence of Hepatitis B Surface Antigen among Undergraduate Students of Gom...Prevalence of Hepatitis B Surface Antigen among Undergraduate Students of Gom...
Prevalence of Hepatitis B Surface Antigen among Undergraduate Students of Gom...
 
Современное лечение ВИЧ.Объединенные данные с конференции IAS 2019 / Contemp...
Современное лечение ВИЧ.Объединенные данные с конференции  IAS 2019 / Contemp...Современное лечение ВИЧ.Объединенные данные с конференции  IAS 2019 / Contemp...
Современное лечение ВИЧ.Объединенные данные с конференции IAS 2019 / Contemp...
 
Rapid HIV Testing: Policy & Regulatory Issues
Rapid HIV Testing: Policy & Regulatory IssuesRapid HIV Testing: Policy & Regulatory Issues
Rapid HIV Testing: Policy & Regulatory Issues
 
Why, when, and how to use pre exposure prophylaxis for hiv acquisition. 2014
Why, when, and how to use pre exposure prophylaxis for hiv acquisition. 2014Why, when, and how to use pre exposure prophylaxis for hiv acquisition. 2014
Why, when, and how to use pre exposure prophylaxis for hiv acquisition. 2014
 
Wepdc204
Wepdc204Wepdc204
Wepdc204
 
Key Slides on ART for HIV : Evolving Concepts and Innovative Strategies.2020
Key Slides on ART for HIV : Evolving Concepts and Innovative Strategies.2020Key Slides on ART for HIV : Evolving Concepts and Innovative Strategies.2020
Key Slides on ART for HIV : Evolving Concepts and Innovative Strategies.2020
 
HPG PrEP Presentation by Dr. Kathleen Brady (AACO)
HPG PrEP Presentation by Dr. Kathleen Brady (AACO)HPG PrEP Presentation by Dr. Kathleen Brady (AACO)
HPG PrEP Presentation by Dr. Kathleen Brady (AACO)
 
Barriers of HIV Prevention through Treatment
Barriers of HIV Prevention through TreatmentBarriers of HIV Prevention through Treatment
Barriers of HIV Prevention through Treatment
 
R4P Abstract
R4P AbstractR4P Abstract
R4P Abstract
 
04.03.20 | COVID-19 and HIV: What We Know and Efforts to Answer What We Don’t...
04.03.20 | COVID-19 and HIV: What We Know and Efforts to Answer What We Don’t...04.03.20 | COVID-19 and HIV: What We Know and Efforts to Answer What We Don’t...
04.03.20 | COVID-19 and HIV: What We Know and Efforts to Answer What We Don’t...
 
Bcn checkpoint - Michael Meulbroek
Bcn checkpoint - Michael MeulbroekBcn checkpoint - Michael Meulbroek
Bcn checkpoint - Michael Meulbroek
 
Using Urine Point-of-Care Tenofovir Testing to Deliver Targeted PrEP Adherenc...
Using Urine Point-of-Care Tenofovir Testing to Deliver Targeted PrEP Adherenc...Using Urine Point-of-Care Tenofovir Testing to Deliver Targeted PrEP Adherenc...
Using Urine Point-of-Care Tenofovir Testing to Deliver Targeted PrEP Adherenc...
 
Review from the 24th Conference on Retroviruses and Opportunistic Infections ...
Review from the 24th Conference on Retroviruses and Opportunistic Infections ...Review from the 24th Conference on Retroviruses and Opportunistic Infections ...
Review from the 24th Conference on Retroviruses and Opportunistic Infections ...
 
Launch of Policy Cures: Improving Access to Diagnostics in the Developing Wor...
Launch of Policy Cures: Improving Access to Diagnostics in the Developing Wor...Launch of Policy Cures: Improving Access to Diagnostics in the Developing Wor...
Launch of Policy Cures: Improving Access to Diagnostics in the Developing Wor...
 

Similaire à HPV infection and anal dysplasia rates in Vancouver MSM

Charlotte Gaydos: Using Self-Collected Specimens to Improve and Extend Delive...
Charlotte Gaydos: Using Self-Collected Specimens to Improve and Extend Delive...Charlotte Gaydos: Using Self-Collected Specimens to Improve and Extend Delive...
Charlotte Gaydos: Using Self-Collected Specimens to Improve and Extend Delive...National Chlamydia Coalition
 
Cost of testing per new HIV diagnosis as a metric for monitoring cost-effecti...
Cost of testing per new HIV diagnosis as a metric for monitoring cost-effecti...Cost of testing per new HIV diagnosis as a metric for monitoring cost-effecti...
Cost of testing per new HIV diagnosis as a metric for monitoring cost-effecti...Carmen Figueroa
 
Cervcal cancer prevention in sa
Cervcal cancer prevention in saCervcal cancer prevention in sa
Cervcal cancer prevention in saTariq Mohammed
 
HPV SCREENING & CO TESTING
HPV SCREENING & CO TESTINGHPV SCREENING & CO TESTING
HPV SCREENING & CO TESTINGNiranjan Chavan
 
Multipex for papillomavirus
Multipex for papillomavirusMultipex for papillomavirus
Multipex for papillomavirusPathKind Labs
 
Male Circumcision Research Into Policy Final S A H A R A Dec 09 2009
Male  Circumcision Research Into Policy Final  S A H A R A  Dec 09 2009Male  Circumcision Research Into Policy Final  S A H A R A  Dec 09 2009
Male Circumcision Research Into Policy Final S A H A R A Dec 09 2009Nicholas Jacobs
 
Male Circumcision Research Into Policy Final Sahara Dec 09 2009
Male Circumcision Research Into Policy Final Sahara Dec 09 2009Male Circumcision Research Into Policy Final Sahara Dec 09 2009
Male Circumcision Research Into Policy Final Sahara Dec 09 2009Nicholas Jacobs
 
Future cervical screening program
Future cervical screening programFuture cervical screening program
Future cervical screening programDonald Angstetra
 
Mancount Sizes Up the Gaps*
Mancount Sizes Up the Gaps*Mancount Sizes Up the Gaps*
Mancount Sizes Up the Gaps*CBRC
 
HIV self-testing and linkage in Africa
HIV self-testing and linkage in AfricaHIV self-testing and linkage in Africa
HIV self-testing and linkage in AfricaCheryl Johnson
 
Cervical cancer hpv-feb07
Cervical cancer hpv-feb07Cervical cancer hpv-feb07
Cervical cancer hpv-feb07Ules Abraham
 
QMU 2 : HPV Screening, May 2015
QMU 2 : HPV Screening, May 2015QMU 2 : HPV Screening, May 2015
QMU 2 : HPV Screening, May 2015Kok-Ming Choo
 
QMU 2: HPV Screening, April 2015
QMU 2: HPV Screening, April 2015QMU 2: HPV Screening, April 2015
QMU 2: HPV Screening, April 2015Quantum Diagnostics
 

Similaire à HPV infection and anal dysplasia rates in Vancouver MSM (20)

Charlotte Gaydos: Using Self-Collected Specimens to Improve and Extend Delive...
Charlotte Gaydos: Using Self-Collected Specimens to Improve and Extend Delive...Charlotte Gaydos: Using Self-Collected Specimens to Improve and Extend Delive...
Charlotte Gaydos: Using Self-Collected Specimens to Improve and Extend Delive...
 
Cost of testing per new HIV diagnosis as a metric for monitoring cost-effecti...
Cost of testing per new HIV diagnosis as a metric for monitoring cost-effecti...Cost of testing per new HIV diagnosis as a metric for monitoring cost-effecti...
Cost of testing per new HIV diagnosis as a metric for monitoring cost-effecti...
 
Cervcal cancer prevention in sa
Cervcal cancer prevention in saCervcal cancer prevention in sa
Cervcal cancer prevention in sa
 
Anal Cytology and Anal Cancer Screening in HIV Patients
Anal Cytology and Anal Cancer Screening in HIV PatientsAnal Cytology and Anal Cancer Screening in HIV Patients
Anal Cytology and Anal Cancer Screening in HIV Patients
 
Epidemiology of gonorrhoea
Epidemiology of gonorrhoeaEpidemiology of gonorrhoea
Epidemiology of gonorrhoea
 
HPV SCREENING & CO TESTING
HPV SCREENING & CO TESTINGHPV SCREENING & CO TESTING
HPV SCREENING & CO TESTING
 
Multipex for papillomavirus
Multipex for papillomavirusMultipex for papillomavirus
Multipex for papillomavirus
 
Male Circumcision Research Into Policy Final S A H A R A Dec 09 2009
Male  Circumcision Research Into Policy Final  S A H A R A  Dec 09 2009Male  Circumcision Research Into Policy Final  S A H A R A  Dec 09 2009
Male Circumcision Research Into Policy Final S A H A R A Dec 09 2009
 
05 Prof~1
05 Prof~105 Prof~1
05 Prof~1
 
Male Circumcision Research Into Policy Final Sahara Dec 09 2009
Male Circumcision Research Into Policy Final Sahara Dec 09 2009Male Circumcision Research Into Policy Final Sahara Dec 09 2009
Male Circumcision Research Into Policy Final Sahara Dec 09 2009
 
14 djmcj 2017_v10_i1_maruf_paps-1
14 djmcj 2017_v10_i1_maruf_paps-114 djmcj 2017_v10_i1_maruf_paps-1
14 djmcj 2017_v10_i1_maruf_paps-1
 
Future cervical screening program
Future cervical screening programFuture cervical screening program
Future cervical screening program
 
Mancount Sizes Up the Gaps*
Mancount Sizes Up the Gaps*Mancount Sizes Up the Gaps*
Mancount Sizes Up the Gaps*
 
1 dr mario sideri
1  dr mario sideri 1  dr mario sideri
1 dr mario sideri
 
HIVR4P Poster
HIVR4P PosterHIVR4P Poster
HIVR4P Poster
 
HIV self-testing and linkage in Africa
HIV self-testing and linkage in AfricaHIV self-testing and linkage in Africa
HIV self-testing and linkage in Africa
 
Cervical cancer hpv-feb07
Cervical cancer hpv-feb07Cervical cancer hpv-feb07
Cervical cancer hpv-feb07
 
QMU 2 : HPV Screening, May 2015
QMU 2 : HPV Screening, May 2015QMU 2 : HPV Screening, May 2015
QMU 2 : HPV Screening, May 2015
 
QMU 2: HPV Screening, April 2015
QMU 2: HPV Screening, April 2015QMU 2: HPV Screening, April 2015
QMU 2: HPV Screening, April 2015
 
Khartoum feb 2008
Khartoum feb 2008Khartoum feb 2008
Khartoum feb 2008
 

Plus de CBRC

Day 1 1100 - travis salway hottes
Day 1   1100 - travis salway hottesDay 1   1100 - travis salway hottes
Day 1 1100 - travis salway hottesCBRC
 
Day 1 1530 - christian hui & alan li
Day 1   1530 - christian hui & alan liDay 1   1530 - christian hui & alan li
Day 1 1530 - christian hui & alan liCBRC
 
Day 2 1300 - investigaytors
Day 2   1300 - investigaytorsDay 2   1300 - investigaytors
Day 2 1300 - investigaytorsCBRC
 
Day 1 1100 - panel - millenials
Day 1   1100 - panel - millenialsDay 1   1100 - panel - millenials
Day 1 1100 - panel - millenialsCBRC
 
Day 2 0900 - robin parry & ben klassen
Day 2   0900 - robin parry & ben klassenDay 2   0900 - robin parry & ben klassen
Day 2 0900 - robin parry & ben klassenCBRC
 
Day 2 0900 - ashleigh rich
Day 2   0900 - ashleigh richDay 2   0900 - ashleigh rich
Day 2 0900 - ashleigh richCBRC
 
Day 2 0900 - robert ablenas
Day 2   0900 - robert ablenasDay 2   0900 - robert ablenas
Day 2 0900 - robert ablenasCBRC
 
Day 2 1500 - chris atchison
Day 2   1500 - chris atchisonDay 2   1500 - chris atchison
Day 2 1500 - chris atchisonCBRC
 
Day 2 1530 - mark gilbert
Day 2   1530 - mark gilbertDay 2   1530 - mark gilbert
Day 2 1530 - mark gilbertCBRC
 
Day 1 0930 - nathaniel lewis
Day 1   0930 - nathaniel lewisDay 1   0930 - nathaniel lewis
Day 1 0930 - nathaniel lewisCBRC
 
Day 1 0915 - terry trussler
Day 1   0915 - terry trusslerDay 1   0915 - terry trussler
Day 1 0915 - terry trusslerCBRC
 
Day 2 1100 - phillip hammack
Day 2   1100 - phillip hammackDay 2   1100 - phillip hammack
Day 2 1100 - phillip hammackCBRC
 
1045 2 bb presentation vancouver
1045 2 bb presentation vancouver1045 2 bb presentation vancouver
1045 2 bb presentation vancouverCBRC
 
1045 1 what new sero-converters in toronto are saying
1045 1 what new sero-converters in toronto are saying1045 1 what new sero-converters in toronto are saying
1045 1 what new sero-converters in toronto are sayingCBRC
 
1045 3 1 final-beyond behaviours slides april 15 v5 Daniel Grace
1045   3 1 final-beyond behaviours slides april 15 v5 Daniel Grace1045   3 1 final-beyond behaviours slides april 15 v5 Daniel Grace
1045 3 1 final-beyond behaviours slides april 15 v5 Daniel GraceCBRC
 
115 2 the gradient copy Terry Trussler
115   2 the gradient copy Terry Trussler115   2 the gradient copy Terry Trussler
115 2 the gradient copy Terry TrusslerCBRC
 
915 beyond behaviors conference 2013 Adam Green
915   beyond behaviors conference 2013 Adam Green915   beyond behaviors conference 2013 Adam Green
915 beyond behaviors conference 2013 Adam GreenCBRC
 
115 1 beyond behaviours minority stress
115   1 beyond behaviours minority stress115   1 beyond behaviours minority stress
115 1 beyond behaviours minority stressCBRC
 
23 chad smithnov1
23 chad smithnov123 chad smithnov1
23 chad smithnov1CBRC
 
22 patricia millernov1
22 patricia millernov122 patricia millernov1
22 patricia millernov1CBRC
 

Plus de CBRC (20)

Day 1 1100 - travis salway hottes
Day 1   1100 - travis salway hottesDay 1   1100 - travis salway hottes
Day 1 1100 - travis salway hottes
 
Day 1 1530 - christian hui & alan li
Day 1   1530 - christian hui & alan liDay 1   1530 - christian hui & alan li
Day 1 1530 - christian hui & alan li
 
Day 2 1300 - investigaytors
Day 2   1300 - investigaytorsDay 2   1300 - investigaytors
Day 2 1300 - investigaytors
 
Day 1 1100 - panel - millenials
Day 1   1100 - panel - millenialsDay 1   1100 - panel - millenials
Day 1 1100 - panel - millenials
 
Day 2 0900 - robin parry & ben klassen
Day 2   0900 - robin parry & ben klassenDay 2   0900 - robin parry & ben klassen
Day 2 0900 - robin parry & ben klassen
 
Day 2 0900 - ashleigh rich
Day 2   0900 - ashleigh richDay 2   0900 - ashleigh rich
Day 2 0900 - ashleigh rich
 
Day 2 0900 - robert ablenas
Day 2   0900 - robert ablenasDay 2   0900 - robert ablenas
Day 2 0900 - robert ablenas
 
Day 2 1500 - chris atchison
Day 2   1500 - chris atchisonDay 2   1500 - chris atchison
Day 2 1500 - chris atchison
 
Day 2 1530 - mark gilbert
Day 2   1530 - mark gilbertDay 2   1530 - mark gilbert
Day 2 1530 - mark gilbert
 
Day 1 0930 - nathaniel lewis
Day 1   0930 - nathaniel lewisDay 1   0930 - nathaniel lewis
Day 1 0930 - nathaniel lewis
 
Day 1 0915 - terry trussler
Day 1   0915 - terry trusslerDay 1   0915 - terry trussler
Day 1 0915 - terry trussler
 
Day 2 1100 - phillip hammack
Day 2   1100 - phillip hammackDay 2   1100 - phillip hammack
Day 2 1100 - phillip hammack
 
1045 2 bb presentation vancouver
1045 2 bb presentation vancouver1045 2 bb presentation vancouver
1045 2 bb presentation vancouver
 
1045 1 what new sero-converters in toronto are saying
1045 1 what new sero-converters in toronto are saying1045 1 what new sero-converters in toronto are saying
1045 1 what new sero-converters in toronto are saying
 
1045 3 1 final-beyond behaviours slides april 15 v5 Daniel Grace
1045   3 1 final-beyond behaviours slides april 15 v5 Daniel Grace1045   3 1 final-beyond behaviours slides april 15 v5 Daniel Grace
1045 3 1 final-beyond behaviours slides april 15 v5 Daniel Grace
 
115 2 the gradient copy Terry Trussler
115   2 the gradient copy Terry Trussler115   2 the gradient copy Terry Trussler
115 2 the gradient copy Terry Trussler
 
915 beyond behaviors conference 2013 Adam Green
915   beyond behaviors conference 2013 Adam Green915   beyond behaviors conference 2013 Adam Green
915 beyond behaviors conference 2013 Adam Green
 
115 1 beyond behaviours minority stress
115   1 beyond behaviours minority stress115   1 beyond behaviours minority stress
115 1 beyond behaviours minority stress
 
23 chad smithnov1
23 chad smithnov123 chad smithnov1
23 chad smithnov1
 
22 patricia millernov1
22 patricia millernov122 patricia millernov1
22 patricia millernov1
 

Dernier

ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMADivya Kanojiya
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
medico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinemedico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinethanaram patel
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfSasikiranMarri
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..AneriPatwari
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 

Dernier (20)

ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
medico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinemedico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicine
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 

HPV infection and anal dysplasia rates in Vancouver MSM

  • 1. HPV infection and anal dysplasia in Vancouver: Preliminary findings from the ManCount Survey Dr. Mark Gilbert BC Centre for Disease Control Gay Men’s Health Summit, Nov 10 ‘09
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7. Results - Participation In total, 252 specimens collected 239 (94.8%) specimens of sufficient quality for testing
  • 8.
  • 9. Results – Anal cytology *satisfactory specimens only Prevalence estimates from other studies in pink font (setting, populations may vary). Category Total (n=149) HIV+ (n=42) HIV- (n=107) Normal cytology 58% [50-66%] 36% [21-50%] 29-76% 66% [57-75%] 68-100% High grade squamous intra-epithelial lesion (HSIL) 11% [6-17%] 31% [17-45%] 5-22% 4% [0-7%] 3-5% Low grade squamous intra-epithelial lesion (LSIL) 19% [13%-25%] 26% [13-40%] 19-49% 16% [9-23%] 7-5% Atypical results (ASCUS, ASC-H) 12% [7-17%] 7% [0-15%] 7-26% 14% [7-21%] 5%
  • 10. Results – HPV infection Betaglobin (marker of adequacy) Number Percent Betaglobin positive 159 / 239 67% [62-72%] Betaglobin negative 80 / 239 33% [28-38%]
  • 11.
  • 12.
  • 13.
  • 14.

Notes de l'éditeur

  1. Lampinen et al. Illustrated instructions for self-collection of anorectal swab specimens and their adequacy for cytological examination. Sex Transm Dis 2006; 33(6):386-388.